Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Valvular Heart Disease

Free Subscription Articles published in Mayo Clin Proc Retrieve available abstracts of 24 articles: HTML format

Single Articles

December 2025
1. DEHARO P, Cuisset T, Saint Etienne C, Bourguignon T, et al
   Surgical vs Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis: A Propensity Score-Matched Analysis.
   Mayo Clin Proc. 2025 Dec 5:S0025-6196(25)00459.
   PubMed    
   
   
   October 2025
2. ISMAYL M, Ahmed H, Goldsweig AM, Eleid MF, et al
   In-Hospital Outcomes and Readmissions Following Transcatheter Mitral Valve Interventions in Octogenarians and Nonagenarians.
   Mayo Clin Proc. 2025 Oct 17:S0025-6196(25)00283.
   PubMed     Abstract available
   
   
   April 2025
3. CALESTINE J, Mathur M
   Locomotor Brachii Sign in Absence of Severe Aortic Regurgitation.
   Mayo Clin Proc. 2025 Apr 7:S0025-6196(25)00142.
   PubMed    
   
   
   
4. LO RUSSO GV, Alarouri H, Chen KW, Chang JH, et al
   Aortic Arch Morphology Is Associated With Long-term Mortality After Transcatheter Aortic Valve Replacement.
   Mayo Clin Proc. 2025;100:749-750.
   PubMed    
   
   
   March 2025
5. OMMEN SR, Nishimura RA, Schaff HV, Dearani JA, et al
   Hypertrophic Cardiomyopathy: State of the Art.
   Mayo Clin Proc. 2025;100:557-566.
   PubMed     Abstract available
   
   
   
6. KUCUK HO, Anand V, Nkomo VT, Alabdaljabar MS, et al
   Natural History of Tricuspid Valve Regurgitation: Understanding the Limitations of Medical Therapy.
   Mayo Clin Proc. 2025;100:440-451.
   PubMed     Abstract available
   
   
   
7. FIORI E, Vanderheyden M, Bartunek J
   Tricuspid Valve Regurgitation Trajectories: From Predicting the Unpredictable to Tailored and Timely Treatment Strategies.
   Mayo Clin Proc. 2025;100:408-411.
   PubMed    
   
   
   February 2025
8. NISHIMURA RA, Ommen SR, Dearani JA, Schaff HV, et al
   Valvular Heart Disease-A New Evolving Paradigm.
   Mayo Clin Proc. 2025;100:358-379.
   PubMed     Abstract available
   
   
   December 2024
9. PATEL N, Shetty NS, Pampana A, Gaonkar M, et al
   Sex-Associated Differences in Clinical Outcomes After Septal Reduction Therapies in Hypertrophic Cardiomyopathy.
   Mayo Clin Proc. 2024;99:1933-1944.
   PubMed     Abstract available
   
   
   July 2024
10. SPOON DB, Tunis S, Giri J, Maddux JT, et al
    Transcatheter Aortic Valve Replacement Outcomes During the Public Health Emergency Flexibility Period.
    Mayo Clin Proc. 2024 Jul 5:S0025-6196(24)00131.
    PubMed     Abstract available
    
    
    March 2024
11. SAN ROMAN JA, Ybarra-Falcon C, Garcia-Gomez M, Ramos N, et al
    Evolution and Prognostic Significance of Patient-Reported Symptoms After Intervention in Severe Aortic Stenosis.
    Mayo Clin Proc. 2024;99:400-410.
    PubMed     Abstract available
    
    
    
12. REDDY YNV
    Heart Failure and Hypertrophic Cardiomyopathy-Looking Back on Decades of Remarkable Progress.
    Mayo Clin Proc. 2024;99:352-354.
    PubMed    
    
    
    
13. KARIM S, Chahal CAA, Sherif AA, Khanji MY, et al
    Re-evaluating the Incidence and Prevalence of Clinical Hypertrophic Cardiomyopathy: An Epidemiological Study of Olmsted County, Minnesota.
    Mayo Clin Proc. 2024;99:362-374.
    PubMed     Abstract available
    
    
    
14. AKODAD M, Rouviere P, Gervasoni R
    A Giant Subacute Aortic Valve Thrombus.
    Mayo Clin Proc. 2024;99:502-503.
    PubMed    
    
    
    February 2024
15. GIUDICESSI JR, Alsidawi S, Geske JB, Newman DB, et al
    Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy.
    Mayo Clin Proc. 2024;99:341-343.
    PubMed    
    
    
    
16. ABBASI MA, El-Am E, Geske JB, Herrmann J, et al
    Cardiotoxicity Risk of Cancer Treatment in Patients With Underlying Cardiomyopathies: Is Hypertrophic Cardiomyopathy Any Different?
    Mayo Clin Proc. 2024;99:191-193.
    PubMed    
    
    
    
17. ZAMPIERI M, Schoonvelde SAC, Vinci M, Meattini I, et al
    Cancer Treatment-Related Complications in Patients With Hypertrophic Cardiomyopathy.
    Mayo Clin Proc. 2024;99:218-228.
    PubMed     Abstract available
    
    
    December 2023
18. HUANG Y, Schaff HV, Swarna KS, Sangaralingham LR, et al
    Benefit of Anticoagulation Early After Surgical Aortic Valve Replacement Using Bioprosthetic Valves.
    Mayo Clin Proc. 2023;98:1797-1808.
    PubMed     Abstract available
    
    
    October 2023
19. DE COLLE C, Paolisso P, Gallinoro E, Bertolone DT, et al
    Association of Mild-to-Moderate Aortic Regurgitation With Outcomes in Heart Failure With Preserved Ejection Fraction.
    Mayo Clin Proc. 2023;98:1469-1481.
    PubMed     Abstract available
    
    
    
20. CHAO CJ, Agasthi P, Girardo M, Barry T, et al
    Using Augmented Mean Arterial Pressure to Identify High Mortality Risk Patients With Moderate Aortic Stenosis.
    Mayo Clin Proc. 2023;98:1501-1514.
    PubMed     Abstract available
    
    
    April 2023
21. RIZZO SA, Yalamuri SM, Rosenbaum AN, Anavekar NS, et al
    Percutaneous Mechanical Circulatory Support as a Bridge to Transplantation in Ebstein Anomaly.
    Mayo Clin Proc. 2023;98:626-630.
    PubMed     Abstract available
    
    
    
22. MEIER D, Webb JG, Sathananthan J
    Subaortic Ring: A Rare Cause of Aortic Stenosis in Late Adulthood.
    Mayo Clin Proc. 2023;98:579-580.
    PubMed    
    
    
    March 2023
23. HULL JV, Padkins MR, El Hajj S, Al-Hijji MA, et al
    Risks of Right Heart Catheterization and Right Ventricular Biopsy: A 12-year, Single-Center Experience.
    Mayo Clin Proc. 2023;98:419-431.
    PubMed     Abstract available
    
    
    
24. BURCZAK DR, Newman DB, Jaffe AS, Ackerman MJ, et al
    High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias.
    Mayo Clin Proc. 2023;98:410-418.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge.